Disease
FDA Approves Roche’s Tecentriq Plus Chemotherapy f...
Roche announced that the US Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane [paclitaxel protein-bound; nab-paclitaxel] and carboplatin) for the i...
December 4, 2019
9:21 am By Neha Mule
Biomica to Collaborate With Weizmann Institute of Sc...
Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd., has announced a collaboration with the Weizmann Institute of Science to dev...
October 29, 2019
2:21 pm By Meeta Ramnani